Azucena Esparís‐Ogando

2.6k citations
45 papers · 2.0k indexed · h-index 27
Topics
Melanoma and MAPK Pathways (16 papers)HER2/EGFR in Cancer Research (13 papers)Protein Kinase Regulation and GTPase Signaling (11 papers)
Partner nations
SpainUnited StatesItaly

In The Last Decade

Azucena Esparís‐Ogando

45 papers receiving 2.0k citations

Peers

Azucena Esparís‐Ogando
Comparison fields: 5 of 84
  • Molecular Biology 1.3k
  • Oncology 861
  • Radiology, Nuclear Medicine and Imaging 310
  • Cancer Research 262
  • Immunology and Allergy 229
Replace Andreas Gschwind with:
Andreas Gschwind Germany
Marc Webster Canada
Maria Sundvall Finland
W. Michael Kavanaugh United States
Elena Díaz‐Rodríguez Spain
Marina Holgado-Madruga United States
Jeffrey D. Bjorge Canada
David R. Kaplan United States
Teresa Klinowska United Kingdom
Maria Rozakis-Adcock Canada
Azucena Esparís‐Ogando relative to Andreas Gschwind Germany Andreas Gschwind's profile →
Citations per field
00.5×1.5×2.1×
Andreas Gschwind · 1×
Citations per year

Countries citing papers authored by Azucena Esparís‐Ogando

Since Specialization
Citations

This map shows the geographic impact of Azucena Esparís‐Ogando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Azucena Esparís‐Ogando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Azucena Esparís‐Ogando more than expected).

Fields of papers citing papers by Azucena Esparís‐Ogando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Azucena Esparís‐Ogando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Azucena Esparís‐Ogando. The network helps show where Azucena Esparís‐Ogando may publish in the future.

Co-authorship network of co-authors of Azucena Esparís‐Ogando

This figure shows the co-authorship network connecting the top 25 collaborators of Azucena Esparís‐Ogando. A scholar is included among the top collaborators of Azucena Esparís‐Ogando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Azucena Esparís‐Ogando. Azucena Esparís‐Ogando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 1
3 7
4 1
5 29
6 18
7 41
8 24
9 77
10 54
11 43
12 76
13 78
14 40
15 3
16 52
17 44
18 46
19 15
20 8

About Azucena Esparís‐Ogando

Azucena Esparís‐Ogando is a scholar working on Immunology and Allergy, Oncology and Molecular Biology, having authored 45 papers that have together received 2.0k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (16 papers), HER2/EGFR in Cancer Research (13 papers) and Protein Kinase Regulation and GTPase Signaling (11 papers). The work is most often cited by research in Immunology and Allergy (229 citations), Oncology (861 citations) and Molecular Biology (1.3k citations). Azucena Esparís‐Ogando has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Atanasio Pandiella, Juan Carlos Montero, Elena Díaz‐Rodríguez, Laura Yuste, Alberto Ocaña, Ruth Rodríguez‐Barrueco, Piero Crespo, Mar Abad, Jesús F. San Miguel and Joaquı́n Teixidó. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026